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Two directed evolution experiments on p-nitrobenzyl esterase
yielded one enzyme with a 100-fold increased activity in aqueous-
organic solvents and another with a 17°C increase in thermosta-
bility. Structures of the wild type and its organophilic and ther-
mophilic counterparts are presented at resolutions of 1.5 Å, 1.6 Å,
and 2.0 Å, respectively. These structures identify groups of inter-
acting mutations and demonstrate how directed evolution can
traverse complex fitness landscapes. Early-generation mutations
stabilize flexible loops not visible in the wild-type structure and set
the stage for further beneficial mutations in later generations. The
mutations exert their influence on the esterase structure over large
distances, in a manner that would be difficult to predict. The loops
with the largest structural changes generally are not the sites of
mutations. Similarly, none of the seven amino acid substitutions in
the organophile are in the active site, even though the enzyme
experiences significant changes in the organization of this site. In
addition to reduction of surface loop flexibility, thermostability in
the evolved esterase results from altered core packing, helix
stabilization, and the acquisition of surface salt bridges, in agree-
ment with other comparative studies of mesophilic and thermo-
philic enzymes. Crystallographic analysis of the wild type and its
evolved counterparts reveals networks of mutations that collec-
tively reorganize the active site. Interestingly, the changes that led
to diversity within the ayb hydrolase enzyme family and the
reorganization seen in this study result from main-chain move-
ments.
D irected evolution allows the rapid and simultaneous explo-ration of sequence, structure, and function space and thus
provides a powerful tool to address biochemical questions
involving protein stability and function. Using low mutation
rates and recombination to minimize the number of silent or
deleterious mutations (1, 2), directed evolution delivers protein
variants that are instructive solutions to defined biochemical or
environmental challenges. Unlike proteins from different spe-
cies, in which the bulk of the mutations arise from genetic drift
(3), sequence or structural alignments of proteins obtained by
directed evolution allow immediate identification of accessible
sequence changes that result in the desired phenotypic changes.
Additionally, mechanisms of response to different, defined
selection pressures can be investigated. This work represents a
structural study of evolutionary divergence in a setting where the
selection pressure, start point, pathway, and endpoint all are well
defined.
The enzyme para-nitrobenzyl (pNB) esterase has been
evolved for increased activity in organic solvents (mutant 5–6c8)
(4, 5) and higher thermal stability (mutant 8g8) (6). The
organophile 5–6c8 was evolved by five generations of error-
prone PCR and gene shuffling. Seven amino acid mutations
(Table 1) yielded an enzyme whose activity toward the pNB ester
of the antibiotic loracarbef (pNB-LCN) in 25% dimethylform-
amide is 100-fold greater than the wild type (WT) (5). Ther-
mophile 8g8, the product of eight generations of laboratory
evolution (the first six of which are described in ref. 6), has 13
amino acid mutations (Table 2) that increase the melting tem-
perature by 17°C (Tm 5 69.5°C), increase the optimal temper-
ature for activity by 15°C (Topt 5 60°C), and increase activity
toward p-nitrophenyl acetate. Here we compare the crystal
structures of the WT, organophile 5–6c8, and thermophile 8g8.
The organophile 5–6c8 was determined to 1.6-Å resolution by a
three-wavelength mercury multiple anomalous dispersion exper-
iment and was used to determine the WT and thermophile 8g8
structures to 1.5 Å and 2.0 Å, respectively. The WT structure
shows high structural similarity to acetylcholine esterase (rms
deviation 5 2.6 Å for the Ca of 460 aligned residues) and bile
salt-activated lipase (rms deviation 5 2.5 Å for the Ca of 444
residues) (7). As with acetylcholine esterase, a large fraction of
the pNB esterase has no defined secondary structure (52%
random coil, 33% a-helix, 14% b-sheet). The structures show
how complex networks of interacting mutations increase the
stability and alter the specificity of pNB esterase.
Materials and Methods
Purification and Crystallization. pNB esterases were expressed by
using a modification of the protocol described by Zock et al. (8).
Cells were grown at 32°C in 23 super broth liquid media in a
10-liter high-density bioreactor (Braun, Melsungen, Germany)
and induced by raising the temperature to 42°C. Esterases were
purified by using a modification of the protocol of Chen et al. (9).
Cells were lysed by French press and pelleted by centrifugation.
The supernatant then was titrated to pH 5.0 and centrifuged.
Ammonium sulfate cuts (45% and 85%) were taken, and the
second pellet was dialyzed against 10 mM Tris (pH 8.5), 50 mM
NaCl, 0.5 mM EDTA, and 0.5 mM DTT. The protein was loaded
onto a 25-ml FF Sepharose DEAE column (Amersham Phar-
macia) and eluted with a salt gradient (50–500 mM NaCl). The
peak containing pNB esterase was concentrated, and buffer was
exchanged into low salt (50 mM NaCl), loaded on a 45-ml Poros
HQ column, and eluted with a salt gradient (50–500 mM NaCl).
pNB esterase eluted as a single peak, which was concentrated
and loaded onto a 150-ml HR Sephacryl S-100 column equili-
brated with 10 mM Tris (pH 7.5), 100 mM NaCl, and 1 mM
methionine. Purified pNB esterase was analyzed by MS and
dynamic light scattering. MS showed a single major species, and
dynamic light scattering showed no measurable polydispersity.
Organophile 5–6c8 crystallized by using the hanging drop
method at 18°C in the optimized conditions of 5 ml of 20 mgyml
5–6c8 and 5 ml of mother liquor [29% PEG 4000, 100 mM Tris
(pH 8.4), 160–185 mM LiSO4, and 8–12% dimethylformamide].
WT and 8g8 crystallized in slightly modified conditions from
5–6c8 [WT: 15 mgyml protein, 28% PEG 4000, 100 mM Tris (pH
8.25), 150 mM LiSO4; 8g8: 15 mgyml protein, 20% PEG 4000,
100 mM Tris (pH 7.5), 200 mM MgOAc2]. All three enzymes
crystallized in the space group P212121, a 5 67 Å, b 5 83 Å,
c 5 99 Å.
Abbreviations: pNB, para-nitrobenzyl; WT, wild type.
Data deposition: The coordinates and structure factors reported in this paper have been
deposited in the Protein Data Bank, www.rcsb.org [PDB ID code 1QE3 (WT), 1QE8 (organo-
phile 5-c68), and 1C00 (thermophile 8g8)].
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Data Collection and Structure Determination. Crystals were frozen
after a 30-sec soak in fresh mother liquor. Native and derivative
data sets were collected at the Advance Light Source beamline
5.0.2. The structure of 5–6c8 was determined by a three-
wavelength Hg multiple anomalous dispersion experiment (see
Table 4, which is published as supplementary material on the
PNAS web site, www.pnas.org). Data were processed with
DENZO and SCALEPACK (10). Scaling and phase determination
were done with SOLVE (11). The phasing figure of merit (FOM)
was 0.54 before solvent flattening and 0.75 after solvent flat-
tening with the program DM (12). Density modification in CCP4
(12) produced a very good map into which ’400 aa were built
with side chains. Phased restrained refinement in CNS (13) and
phase combination in CCP4 (12) allowed the remainder of the
structure to be built. The model was refined into the native data,
by using rigid body refinement, followed by Powell minimization,
and individual B-factor refinement, resulting in an Rfree of 42%
and Rcryst of 38%. Alternate rounds of model building in O (14)
with CCP4 (12) generated omit maps, and refinement with CNS
(13) resulted in the final model summarized in Table 3. WT and
8g8 crystallized in isomorphous cells and were solved with direct
replacement by using the 5–6c8 model. All native data were
processed and scaled with DENZO and SCALEPACK (10). In both
cases initial R factors were in the low 50s but dropped into the
low 30s after rigid body refinement (6.0–3.0 Å). Further refine-
ment using all data (25 Å-dmin) and building into omit maps
produced the models described in Table 3. For all models,
refinement using CNS included simulated annealing, Powell
minimization, and individual B-factor refinement (13).
Overall Structure Description
Bacillus subtilis pNB esterase (Fig. 1) is an ayb protein of 489 aa
composed of a central 13-stranded b-sheet surrounded by 15
a-helices. Residues 66–74 and 414–420 in the WT structure are
not observed in the electron density. However, analysis by MS
identified only the N-terminal methionine as deleted. These
residues therefore are presumably unstructured or in multiple
conformations and contribute only weakly to the measured
diffraction intensities.
Based on sequence and structural homology, pNB esterase
belongs to the ayb hydrolase family (17) and contains a catalytic
triad formed by Ser-189, His-399, and Glu-310 (Fig. 1). The
active site is located at the base of a cavity with dimensions 20
Å by 13 Å by 18 Å. pNB esterase shares with acetylcholine
esterase a rare use of Glu instead of Asp as the active site
carboxylate (18). The entrance to the active site is formed by four
loops that reorganize substantially in response to selection
pressure. Residues 64–71 and 413–417, which are in the un-
structured WT loops, form one side of the entrance. The rest of
the entrance is formed by residues 316–320 (poorly structured
electron density in WT) and 260–268. The active site cavity,
which also changes structure substantially in the evolved ester-
ases, is comprised of residues 105–108, 193, 215–216, 268–275,
310–314, 362–363, and 399–400.
Structural Evolution of an Organophile
The organophile 5–6c8 structure is overall quite similar to WT,
with a rms deviation of 0.67 Å for all C-a atoms (467 residues).
The positions and orientations of the catalytic triad are unal-
tered by the mutations. However, the mutations have dramatic
effects on the surface loops that form the opening to the active
site and on residues that form the sides of the active site. None
of the seven substitutions in 5–6c8 (Table 1 and Fig. 1B) is in the
active site, and only one is in the entrance. These substitutions
serve, however, to decrease the flexibility of surface loops and
reorganize the active site for substrate pNB-LCN (the pNB ester




S189 Og Proposed role for 5-6c8 mutations
H322R 1 21.8 Å Stabilizes 314–324 loop. Moves 265-275 active site forming loop. Interacts with M358V, L144M, and
L334S.
Y370F 1 16.3 Å Perhaps results in more favorable solvation.
M358V 2 11.4 Å Reorganizes 265–275 and 315–325 loops. Interacts with L144M. H322R, and L334S.
L144M 3 18.5 Å Reorients helix 9, which stabilizes 265-275 loop. Interacts with M358V, H322R, and L334S.
160V 4 18.1 Å Stabilizes 66–74 loop, allows 10 intramolecular H bonds.
L334S 4 17.1 Å Stabilizes movement of helix 9 and 265-275 loop. Interacts with H322R, M358V, and L144M.
P317S 5 20.8 Å Perhaps stabilizes new orientation of 315-324 loop.






S189 Og Proposed role for 8g8 mutations
160V 1 2 17.0 Å Stabilizes 64–74 and 414–420 loops. Allows 10 intramolecular H bonds.
L144M 1 1 17.8 Å Stabilizes 265–275 loop. Interacts with M358V, H322Y, and L343.
M358V 1 1 11.9 Å Shifts 265-275 and 315-324 loops (smaller shift than 56c8). Interacts with H322Y, L144M, and A343V.
Y370F 1 3 16.5 Å Perhaps results in more favorable solvation.
A343V 2 1 25.0 Å Alters packing among helices 9, 10, 11, and 15.
1437T 3 3 21.7 Å Forms intramolecular H bond, stabilizing helix 17.
H322Y 4 1 20.8 Å Positions 315–324 loop. Determines the interaction between 265-275 active site loop and 315-324
loop. Interacts with M358V, L144M, and A343V.
L313F 5 3 10.7 Å Forms face-to-edge interaction with F314.
G412E 5 2 17.0 Å Precedes 413–421 loop, which is unstructured in WT. Forms salt bridge with R415.
T73K 7 2 21.1 Å In 65–75 loop, which is unstructured in WT. Forms salt bridge with E74.
T459S 7 4 28.4 Å Thr and Ser both H bond to H456. Small cost of exposing a methyl group is saved.
A56V 8 4 25.8 Å No observable changes.
A400T 8 3 7.8 Å Thr-400 is in the active site.
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of the antibiotic loracarbef). The 315–324 loop, poorly struc-
tured in the WT, is well defined in both organophile 5–6c8 and
thermophile 8g8 (Fig. 1). As shown in Fig. 2A, the His-3223Arg
mutation from the first generation plays a major role. The side
chain of 322 in 5–6c8 points ’95° away from its position in WT
and directly toward the 265–275 loop. In 5–6c8, the guanidino
group of Arg-322 H-bonds to the main-chain oxygen of Asp-268
and contributes to a binding pocket for a well-defined sulfate,
which in turn H-bonds to Lys-267 (the sulfate binding pocket is
formed by Lys-267, Arg-322, Ser-323, and Thr-326). This hydro-
gen bonding network reorganizes the 265–275 loop that forms a
face of the active site and stabilizes the 265–275 and 315–324
loops by introducing hydrogen bonds between them.
Reorganization of the active site is further affected by a group
of three interacting mutations: Met-3583 Val, Leu-1443Met,
and Leu-334 3 Ser. As shown in Fig. 2B, Met-358 3 Val is
located in helix 11, which packs against loop 315–324. The
Met-3583 Val mutation allows Phe-314 (at the end of helix 8)
to shift toward the space previously occupied by the longer Met
side chain, shifting loop 315–324 and the following helix (helix
8). This rearrangement accommodates the Pro-317 3 Ser
mutation. Phe-314 in either orientation forms a part of the active
site pocket. Additionally, Leu-362 rotates ’70° toward the active
site. The largest change allowed by the Met-3583 Val mutation
is a 2-Å movement of residue Phe-271 into the area previously
occupied by Met-358. This movement shifts a 17-aa stretch from
258–275, which forms the entrance to the active site as well as
forming a face of the active site. The new loop orientation is
further stabilized by Leu-144 3 Met (Fig. 2C), which allows
Phe-233 to rotate 50° around x1 and 30° around x2. This allows
Leu-262 to shift into the vacated space, resulting in a reorien-
tation of helix 9 that stabilizes the new orientation of the 265–275
loop. Finally, the last of these three mutations, the fourth-
generation Leu-334 3 Ser mutation, accommodates the move-
ment of Phe-271 (Fig. 2B).
Fig. 1. MOLSCRIPT diagrams (15, 16) of pNB esterases looking into the active site cavity, showing loops that are not visible in the electron density as dashed lines
and loops that reorganize most significantly in gold. The catalytic triad is shown in red and mutations are shown in blue. (A) The WT structure with secondary
structural elements labeled. (B) The 5–6c8 structure. (C) The 8g8 structure, rotated slightly from the others to clarify the location of the mutations. (D) A wall-eyed
stereo overlay of the Ca positions of the three structures, oriented as in A and B. WT is shown in blue, organophile 5–6c8 in green, and thermophile 8g8 in purple.
Table 3. Structure refinement statistics for pNB esterases
Protein Resolution Å Rfree Rcryst
rms deviation
Amino acids #Waters #IonsBonds Angles
5-6c8 25–1.6 23.2 21.8 0.0055 1.470 2–484 272 2
WT 25–1.5 24.0 22.0 0.0049 1.348 2–65, 75–413,
421–484
380 2
8g8 25–2.0 24.9 21.1 0.0059 1.313 2–484 161 1
Rfree 5 Rcryst calculated with 10% of the data chosen at random and not used in refinement. Rcryst 5 100*SuFobs 2 Fcalcu/SuFobsu, where Fobs and Fcalc are the
observed and calculated structure factors.








Ile-60 3 Val, found in the fourth generation, stabilizes a
surface loop that is unstructured in the WT enzyme. The
replacement of Ile-60 with the smaller valine allows the 66–74
loop to pack against residues 60–63 and 110–116 in a manner
that would cause steric clashes between side chains of residues
60 and Leu-68 if both adopted conformations similar to the WT.
The alternate loop structure of residues 66–74 in 5–6c8 provides
10 additional H bonds.
Mutation Tyr-3703 Phe is buried and results in no structural
changes. An H bond, from the side chain or Tyr-370 to the
main-chain carbonyl of 196, formed in the WT is lost in 5–6c8.
However, this may not compensate the higher cost of desolvating
Tyr versus Phe.
Structural Evolution of a Thermophile
Currently, at least 13 pairs of mesophile and thermophile
structures have been determined (for a recent review see ref. 19).
However, these structures are of significantly divergent proteins
with sequence identities as low as 36% and in no cases exceeding
75% (19), a fact that hinders the assignment of stabilizing
mechanisms (19–21). By contrast, the most thermophilic variant
of pNB esterase, 8g8, with only 13 mutations is 97% identical to
WT and has a rms deviation of 0.44 Å for C-a atoms (467
residues). As with 5–6c8, the catalytic triads are superimposable.
This high sequence identity, in conjunction with the crystal
structures of both WT and thermophile, affords an interesting
opportunity to study the structural basis for thermostability.
Thermophile 8g8 is the product of eight generations of directed
evolution for retention of activity toward p-nitrophenyl acetate
after incubation at high temperature (ref. 6 and data not shown).
The starting point was a thermophilic esterase from a pre-
existing library (generated for the organophile study) that
already contained Ile-603Val, Leu-1443Met, His-3223Arg,
Tyr-370 3 Phe, and Met-358 3 Val.
As with organophile 5–6c8, the mutations in thermophile 8g8
serve to both reorganize the active site and stabilize surface
loops. The 13 mutations in 8g8 fall into four groups. Mutations
in the first group (Leu-144 3 Met, Met-358 3 Val, His-322 3
Tyr, and Ala-343 3 Val) all interact to reorganize the 265–275
and 315–324 loops. A second group (Ile-60 3 Val, Gly-412 3
Glu, and Thr-733 Lys) stabilizes the 66–74 and 414–420 loops.
These loops, which do not contribute to the lattice structure in
any of these isomorphous crystals, are unstructured in WT.
Mutations Tyr-3703 Phe, Leu-3133 Phe, Ile-4373 Thr, and
Ala-400 3 Thr have isolated, interpretable effects, whereas
mutations Thr-459 3 Ser and Ala-56 3 Val cannot be ex-
plained. The 13 mutations and their putative stabilization mech-
anisms are summarized in Table 2.
The first group contains two mutations, Leu-144 3 Met and
Met-3583 Val, that are found in organophile 5–6c8. Although
they make similar contacts in both structures, the overall effect
in the thermophile is greatly influenced by a third mutation,
Arg-322 3 Tyr. Met-358 3 Val allows Ile-270, Leu-362, and
Phe-315 to move, but the large reorganization of the 258–275
stretch in the organophile is not observed in the thermophile.
Likewise, the movement in the 315–348 stretch is much less
substantial (compare Figs. 2 and 3). The explanation for why
identical mutations have different structural (and functional)
results involves the role of residue 322 (Figs. 2 A and 3A), which
differs in all three proteins. This site dictates the nature of the
interaction between the 315–324 loop and the 265–275 loop. In
the evolution of thermophile 8g8, residue 322 starts as an
arginine, then mutates to a cysteine and finally to a tyrosine (6).
In thermophile 8g8 the 265–275 loop follows WT much more
closely than in organophile 5–6c8, but the 315–324 loop is pulled
closer to the active site. Residue 322 moves 2.5 Å (measured at
Ca) from its WT position, and Cb points ’90° away from its WT
position and toward the 265–275 loop. Unlike Arg-322, Tyr-322
does not interact directly with the adjacent 265–275 loop (except
for a 3.5-Å H bond to the backbone amide of residue 270). The
new position of the 315–324 loop allows Ser-323 to H-bond to
Thr-326, stabilizing the loop and helix 8. A fourth mutation,
Ala-343 3 Val, is in helix 10, which packs against helices 9, 11,
and 15. To accommodate the movement of loop 315–324, helix
10 moves closer to helix 9 and further from helix 11, resulting in
space nicely filled by the Ala-343 3 Val mutation.
The second group of interacting mutations (Ile-60 3 Val,
Gly-4123Glu, and Thr-733 Lys) stabilizes the loops that form
the opening to the active site cavity (Fig. 1C). These loops are
also well defined in organophile 5–6c8; therefore, the stabiliza-
tion of 66–74 by Ile-60 3 Val appears to also fix the adjacent
414–420 loop. Gly-412 3 Glu is not necessary for the stabili-
zation of 413–421, but it forms a salt bridge with Arg-415, which
stabilizes helix 12. This interaction has been shown by mutational
analysis to contribute to thermostability (6). The Thr-733 Lys
mutation is also in the loop stabilized by Ile-60 3 Val, and its
Fig. 2. Comparison between organophile 5–6c8 (green) and WT (blue). (A) A superposition of the 315–324 and 265–275 loops. The His-3223 Arg mutation
results in a hydrogen bond to the main-chain oxygen of Asp-268. Arg-322 also contributes to a binding pocket for a well-defined sulfate. The sulfate is oriented
by hydrogen bonds to Ser-323 and Thr-326, as well as salt bridges to Lys-267 and Arg-322. The His-3223 Arg mutation results in two interactions between loop
265–275 and loop 315–324. (B) A superposition of the main chain in the vicinity of changes introduced by the Met-3583 Val and Leu-3343 Ser mutations. The
mutation to a smaller side chain at 358 allows Phe-314 to rotate into the area vacated, shifting loop 315–324. Leu-362 also rotates into the vacated space, as does
Phe-271, resulting in a shift of residues 258–275, which form a face of the active site. The changes caused by the third-generation Met-3583 Val mutation are
stabilized by the fourth-generation Leu-3343 Ser mutation, which accommodates the new orientation of Phe-271. (C) The new orientation of 265–275 caused
by the second-generation Met-358 3 Val mutation is stabilized by the fourth-generation Leu-144 3 Met mutation. Leu-144 3 Met allows Phe-233 to shift,
accommodating the new position of Leu-262 and stabilizing the new orientation of 258–275.
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WT position is therefore unknown. In the thermophile 8g8
Lys-73 forms a salt bridge with Glu-74. Both Gly-4123Glu and
Thr-733 Lys occur after the 66–74 and 414–420 loops are fixed
(the loops are fixed in the first generation) and are thus clear
examples of stabilizing salt bridges that could not be designed
into the WT background, illustrating the power of iterative
methods in protein engineering.
Mutations in the third group, Tyr-3703 Phe, Leu-3133 Phe,
Ile-437 3 Thr, and Ala-400 3 Thr all have been shown by
biochemical studies to be thermostabilizing (6). Tyr-3703 Phe
results in no structural changes other than the loss of an H bond
between Tyr-370 and the main-chain carbonyl of residue 196. As
mentioned above, the higher cost of desolvating Tyr versus Phe
may explain how this mutation stabilizes the enzyme. Leu-3133
Phe results in a stabilizing face-to-edge interaction (22, 23) with
Phe-314. Ile-4373 Thr is in helix 13 and results in an intra-helix
H bond to the main-chain oxygen of 433, stabilizing the helix.
Ala-400 3 Thr is not thermostabilizing when introduced into
WT as a double mutant with Ala-56 3 Val, the other eighth-
generation mutation (data not shown). However, it may be
thermostabilizing in the seventh-generation background or may
be responsible for the increased activity of 8g8. Although residue
400 is visible in all structures, Thr-400 packs against Met-416,
which is not visible in the WT structure. Met-416 is shifted away
from residue 400 in the thermophile relative to the organophile,
because of the salt bridge introduced by the fifth-generation
Gly-412 3 Glu mutation. The movement of Met-416 is accom-
modated by the larger Thr side chain. Furthermore, the Thr-400
side chain is in the active site and may help stabilize His-399.
As seen in antibody maturation structural studies, not all
mutations can be rationalized even with structures for compar-
ison (24, 25). Thus although screening mutant libraries often can
identify interesting proteins, neutral mutations do arise. The
ability of recombination to remove neutral mutations (1, 2)
(performed most recently after the seventh generation in the
evolution of 8g8) presents a tool to be enlisted in the study of
somatic mutation in the immune system. Thr-459 3 Ser and
Ala-56 3 Val are two neutral mutations in thermophile 8g8.
Both are exposed to solvent and are more than 25 Å from the
active site. The mutation at 459 appeared in the same generation
with a known stabilizing mutations and therefore may not be
stabilizing itself.
Relevance to Protein Engineering
Directed evolution offers an efficient route to redesigning
proteins for new functional characteristics. Adaptive mutations
and well-defined selection pressures allow structural analysis of
the evolved products to provide insights into the molecular basis
of protein function. Here, the stabilization of a monomeric
protein is accompanied by altered core packing, helix stabiliza-
tion, introduction of surface salt bridges and reduction of
flexibility in surface loops, all of which are proposed mechanisms
by which proteins from thermophiles are stabilized (19–21, 26).
The thermostabilizing mechanisms that were recruited in 8g8
represent a far from exhaustive list of the mechanisms identified
in naturally thermostable proteins. A reduction of internal cavity
volume, introduction of salt bridge clusters, decreased surface
area to volume ratio, removal of redox active residues, burial of
exposed hydrophobic residues, elimination of b-branched amino
acids, and removal of amino acids that can deamidate, all
proposed routes to enhanced thermostability (19), were not
observed in this experiment. Some of these mechanisms may not
be accessible via a single amino acid mutation pathway, requiring
instead multiple simultaneous and compensating mutations.
Others may not become apparent under heavy selection pressure
that requires measurable changes (1–2°C) in thermostability
with each generation. Still others will be associated with deac-
tivation mechanisms that are not important at the temperature
(’70°C) and time scale of the directed evolution experiment
(e.g., chemical modification of amino acids).
The membership of pNB esterase in the diverse group of ayb
hydrolases invites comparisons of how directed and natural
evolution solve challenges requiring adaptation to new biochem-
ical tasks. The two enzymes with which pNB esterase shares the
greatest structural identity are acetylcholine esterase (AChE)
and bile-salt activated lipase (7), both of which differ from pNB
esterase in the loops affected by directed evolution. Both di-
rected and natural evolution introduce main-chain movements
into the loops around the active site. The changes introduced by
directed evolution are similar to the main-chain movements seen
in members of the ayb hydrolase family. In AChE, recognition
of the small acteylcholine substrate is aided by the loop homol-
ogous to the 64–78 loop in pNB esterase. In AChE the 64–78
loop is replaced by a longer (21 aa) loop that shrinks the active
site, which is advantageous for hydrolyzing the smaller acetyl-
choline substrate, by inserting large residues, Met-83 and Trp-84,
into the binding cleft. While the experiments conducted on pNB
esterase produced variants with conserved loop lengths, natural
evolution and V(D)J recombination (the combinatorial gene
shuffling procedure the immune system uses to produce large
libraries of antibodies) use loop length variation to enhance
diversity. It should be possible to introduce this feature into
Fig. 3. Comparison between the thermophile 8g8 (purple) and WT (blue). (A)
A superposition of the 315–324 and 265–275 loops. The His-3223 Tyr muta-
tion introduces a direct interaction between the loops. The 315–324 loop is
pulled closer to the active site to accommodate the smaller substrate, allowing
a 3.5-Å H bond between Tyr-322 and the main-chain N of Ile-270. Additionally,
the new orientation of 315–324 allows an H bond between the side chains of
Ser-323 and Thr-326, stabilizing helix 12 and the 315–324 loop. (B) A super-
position of WT and 8g8 shows the effect of the Met-3583Val mutation. In the
absence of the His-3223 Arg mutation, the large reorganization of 265–275
is not seen. Leu-362 and Ile-270 move to fill the cavity created by the Met-358
3 Val mutation.








directed evolution libraries by mixing parent sequences from
different species (27).
The complex changes brought about by directed evolution
underscore the difficulty of the rational design problem. Some
efforts to simplify the rational design problem have focused on
the additivity of single site mutations (28, 29). Mutations are
considered additive when the effect of multiple mutations and
the sum of the effects of single site mutants are equal, and the
effect being measured is a state function. Such additivity is
observed when the individual mutation sites do not interact with
each other or do not alter the rate-determining step in catalysis
(29). However, in addition to these limitations, the reported
precision of such results may not be adequate to have broadly
predictive value (30). Directed evolution, in which mutations in
the later generations interact with the results of previous mu-
tations, can reveal nonadditive mutation pathways. The intro-
duction of interacting mutations in successive generations indi-
cates that rational design will benefit from efforts to predict the
effects of single mutations and then introduce later-generation
mutations in an iterative manner.
However, even given a high-resolution crystal structure, it is
unlikely that the mutations discovered in these experiments
could have been predicted. Mutations that fix disordered regions
of pNB esterase were found in both evolutionary experiments.
The lack of defined electron density for these regions in the WT
crystal structure certainly would have precluded rational design
to stabilize them. Three of the mutations in thermophile 8g8,
Ile-603Val, Gly-4123Glu, and Thr-733Lys, interact directly
with regions that are unstructured in the WT. Additionally, these
mutations interact with Met-3583Val, Ala-3433Val, Leu-144
3 Met, and His-322 3 Tyr, thus a majority of the stabilizing
mutations are functionally related to regions that are unstruc-
tured in the WT enzyme. Some mutations that affect the active
site were found to do so by transmitting subtle changes into more
significant active site perturbations. The increased activity of the
organophile is a result of mutations outside the active site, which
nonetheless affect significant reorganization of the active site
cavity. The Leu-1443Met, Ala-3433Val, and Met-3583Val
mutations shift a-helices, which, in turn, reorient loops forming
the active site. Recently, the structure of an amino-transferase
directed evolution product was reported (31). Those authors also
found clusters of interacting mutations distant from the active
site. The ability of directed evolution to identify structurally and
functionally important amino acid clusters in proteins is similar
to the immune system’s ability to control the shapes of the
complementarity determining regions of antibodies with a small
number of critical sites (32). Both methods point to the existence
of mutational hotspots that influence function across long
distances.
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